ACCEPTED MANUSCRIPT

Design and characterisation of a minibeam collimator utilising Monte Carlo simulation and a clinical linear accelerator

, , , and

Accepted Manuscript online 17 May 2024 © 2024 Institute of Physics and Engineering in Medicine

What is an Accepted Manuscript?

DOI 10.1088/1361-6560/ad4d52

10.1088/1361-6560/ad4d52

Abstract

Spatially fractionated radiotherapy is showing promise as a treatment modality. Research has primarily focused on applications in proton therapy, however, there is some evidence that minibeam effects may also be present in photon therapy.

This study presents a 3D printed tungsten minibeam collimator intended to produce peak-to-valley dose ratios (PVDR) of between seven and ten with a 1 MeV, bremsstrahlung generated, photon beam. The design of the collimator is motivated by a Monte Carlo study estimating the peak to valley dose ratio for different collimator designs at different energies. This collimator was characterised on a clinical linear accelerator (Elekta VersaHD).

It was found that 1 MeV photon sources may generate PVDRs in the region of seven. The performance of the fabricated collimator was measured on a 250 keV superficial treatment unit and an Elekta VersaHD running in unflattened mode with a 6 MV beam. On the superficial unit the measured PVDR was greater than 10. On the Elekta VersaHD units the PVDR was measured to be between approximately 1.5 and 2.0 at 3 cm deep.

Export citation and abstract BibTeX RIS

During the embargo period (the 12 month period from the publication of the Version of Record of this article), the Accepted Manuscript is fully protected by copyright and cannot be reused or reposted elsewhere.

As the Version of Record of this article is going to be / has been published on a subscription basis, this Accepted Manuscript will be available for reuse under a CC BY-NC-ND 3.0 licence after the 12 month embargo period.

After the embargo period, everyone is permitted to use copy and redistribute this article for non-commercial purposes only, provided that they adhere to all the terms of the licence https://creativecommons.org/licences/by-nc-nd/3.0

Although reasonable endeavours have been taken to obtain all necessary permissions from third parties to include their copyrighted content within this article, their full citation and copyright line may not be present in this Accepted Manuscript version. Before using any content from this article, please refer to the Version of Record on IOPscience once published for full citation and copyright details, as permissions may be required. All third party content is fully copyright protected, unless specifically stated otherwise in the figure caption in the Version of Record.

10.1088/1361-6560/ad4d52